Essay examines tensions in longevity between improving healthspan with basic care and pursuing radical biological and technological augmentation, highlighting equity and social questions as AI and BCIs converge with the field.
Key Takeaways
- Typical longevity programs currently cost roughly $20K–$40K per year while advanced therapies
- Healthspan is only one part of the story
- Is longevity becoming a slippery slope toward transhumanism?